EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Approach to the Patient: Hereditary Medullary Thyroid Carcinoma

Omair A Shariq, Steven G Waguespack, Sarah Hamidi, Benjamin C Kensing, Mimi I Hu, Catherine M Skefos, Nancy D Perrier iD

The Journal of Clinical Endocrinology & Metabolism · 07.08.2025 · 110 (9) · 2685-2697

DOI: 10.1210/clinem/dgaf089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 19.03.2025. Verfasst von Omair A Shariq und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Multiple Endocrine Neoplasia Type 2a, Carcinoma, Neuroendocrine, Carcinoma, Medullary. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 127 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medullary thyroid carcinoma is a rare neuroendocrine tumor originating from calcitonin-secreting parafollicular C cells of the thyroid gland. Approximately 25% of cases in adults are hereditary medullary thyroid carcinoma (hMTC), arising from activating, germline pathogenic variants in the REarranged during Transfection (RET) proto-oncogene and causing the syndromes multiple endocrine neoplasia (MEN) types 2A and 2B. A paradigmatic feature of MEN2 is its robust genotype-phenotype correlations, which predict the disease spectrum and age of onset of hMTC and other clinical manifestations. Advances in genetic testing and systemic therapies and an improved understanding of the natural course of MEN2 have transformed the clinical presentation of hMTC from advanced-stage disease to early detection in asymptomatic RET pathogenic variant carriers. The management of hMTC has similarly evolved from aggressive, one-size-fits-all surgical approaches to personalized strategies informed by genotype, biochemical markers, and imaging findings. Risk-reducing early thyroidectomy remains the cornerstone of metastatic hMTC prevention, with the timing of surgery tailored to the specific pathogenic variant and clinical context. Additionally, recent advances in targeted systemic therapies offer promising options for patients with recurrent and/or metastatic disease. This “Approach to the Patient” article explores the diagnostic evaluation, surgical decision-making, systemic treatment options, and follow-up of patients with hMTC, emphasizing the critical role of multidisciplinary care in optimizing outcomes for patients and their families.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsMultiple Endocrine Neoplasia Type 2aCarcinoma, NeuroendocrineCarcinoma, MedullaryHumansProto-Oncogene MasThyroidectomyProto-Oncogene Proteins c-retGerm-Line MutationGenetic Testing

Stichwörter der Autor:innen

MEN2RETpediatricprophylacticrisk-reducingthyroidectomy

Substanzen

Proto-Oncogene MasMAS1 protein, humanProto-Oncogene Proteins c-retRET protein, human

Autor:innen und Institutionen

  • Department of Surgical Oncology, Section of Surgical Endocrinology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Department of Pediatrics-Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Clinical Cancer Genetics Program, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

ORCID-Profile: Nancy D Perrier

Zitieren

APA

Shariq, O. A., Waguespack, S. G., Hamidi, S., Kensing, B. C., Hu, M. I., Skefos, C. M., & Perrier, N. D. (2025). Approach to the Patient: Hereditary Medullary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism, 110(9), 2685-2697. https://doi.org/10.1210/clinem/dgaf089

Vancouver

Shariq OA, Waguespack SG, Hamidi S, Kensing BC, Hu MI, Skefos CM, et al. Approach to the Patient: Hereditary Medullary Thyroid Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 2025;110(9):2685-2697. doi:10.1210/clinem/dgaf089

BibTeX
@article{Shariq2025,
  author = {Shariq, Omair A and Waguespack, Steven G and Hamidi, Sarah and Kensing, Benjamin C and Hu, Mimi I and Skefos, Catherine M and Perrier, Nancy D},
  title = {Approach to the Patient: Hereditary Medullary Thyroid Carcinoma},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {9},
  pages = {2685--2697},
  doi = {10.1210/clinem/dgaf089}
}
Kostenlos starten →